Securities code: 300199 securities abbreviation: Hybio Pharmaceutical Co.Ltd(300199) Announcement No.: 2022-023
Hybio Pharmaceutical Co.Ltd(300199)
About controlling shareholders, actual controllers and persons acting in concert
Announcement on the cancellation of pledge of some shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records
Contains, misleading statements or material omissions.
Special risk tips:
The controlling shareholder of Hybio Pharmaceutical Co.Ltd(300199) (hereinafter referred to as "the company" or " Hybio Pharmaceutical Co.Ltd(300199) ")
Mr. Zeng shaogui, the actual controller, has pledged 152590000 shares of the company, accounting for his shares of the company
The number proportion exceeds 80%, and Mr. Zeng Shaoqiang, the controlling shareholder and the actual controller acting in concert, has pledged the company accumulatively
The number of shares is 106173648, accounting for more than 80% of the company's shares. Please pay attention to investors
Investment risk.
Recently Hybio Pharmaceutical Co.Ltd(300199) received a notice from Mr. Zeng Shaobin, the controlling shareholder and actual controller of the company,
Mr. Zeng Shaobin handled the pledge cancellation of some shares. The relevant information is hereby announced as follows:
1、 Basic information of this pledge cancellation
Whether it is the shareholder controlling the released shares or whether the Pledged Shares are released on the pledge start date, and whether the pledge release date accounts for the largest number of shares (shares) of the company except the pledge name It refers to the proportion of the total share capital of the pledgee in its East and its first share sale proportion, and the proportion of the person holding the shares to act
Zeng Shaobin is 3000000 no 2021.1.19 2022.1.27 Shenzhen hi tech investment small loan Co., Ltd. 0.33% 10.36%
Total 3000000 ---- 0.33%-
2、 Cumulative pledge of shareholders' shares
As of the disclosure date of this announcement, the shares held by the controlling shareholders, actual controllers and persons acting in concert of the company have been pledged
The situation is as follows:
Number of shares held by shareholders and shareholding ratio of this pledge to its share of the company pledged
Weighing (share) example: total shares of the company held by pledge before pledge and pledge after pledge, non Pledged Shares, pledged shares, pledged shares and share capital
Quantity proportion pledged to pledged (share) (share) Share restricted pledge share restricted pledge sale and frozen share sale and frozen share settlement quantity proportion (share) (share)
Zeng shaogui 153606 16.75% 152590 152590 99.34 16.64 114206 74.85
,167 ,000 ,000 % % ,986 % 997,639 0.65%
Zeng Shaoqiang 107047 11.67% 106173 106173 99.18 11.58 80183, 75.52
,840 ,648 ,648 % % 302 % 102,578 0.10%
Zeng Shaobin 28956, 3.16%, 25000, 22000, 75.98, 2.40%, 21710, 98.69
024 000 000 % 994 % 6,024 0.03%
Total 289610 31.58% 283763 280763 96.95 30.62 216101 1106,2
,031 ,648 ,648 % % ,282 - 41 -
4、 Other information
1. Controlling shareholder and actual controller Mr. Zeng shaogui and persons acting in concert Mr. Zeng Shaoqiang and Mr. Zeng Shaobin
The Pledged Shares are mainly used to repay the pledged loans in the early stage, and the repayment funds are expected to come from self owned and self raised funds.
2. Controlling shareholder and actual controller Mr. Zeng shaogui and persons acting in concert Mr. Zeng Shaoqiang and Mr. Zeng Shaobin
The cumulative number of pledged shares due within the next six months is 8553600 shares, accounting for 20% of the total shares of the company
2.95%, accounting for 0.93% of the total share capital of the company, and the corresponding financing amount is 35 million yuan; Pledged shares due within the next year
The cumulative number of shares is 280.7636 million, accounting for 96.95% of the total shares of the company and accounting for the total share capital of the company
30.62%, and the corresponding financing amount is 1303.9 million yuan.
As of the disclosure date of the announcement, the personal credit and financial status of the controlling shareholders, actual controllers and persons acting in concert
The business is in good condition and has the corresponding capital repayment ability. It is expected that the sources of repayment funds in the future will be self owned and self raised funds.
There is no risk of closing positions or forced transfer of ownership of its shares.
3. The controlling shareholders, actual controllers and persons acting in concert do not have non operating fund occupation or illegal guarantee
And other violations of the interests of listed companies.
4. The above actions will not lead to the change of the company's actual control, and will not affect the company's production and operation and corporate governance
Have an impact. At present, Mr. Zeng shaogui has no risk of closing positions or being forced to close positions. In case of subsequent occurrence of the above
Risk, it will take measures including but not limited to early repurchasing, supplementing the pledged underlying securities and so on. The company will hold
Strictly disclose the pledge and relevant information in a timely manner,
Please pay attention to investment risks.
It is hereby announced.
Hybio Pharmaceutical Co.Ltd(300199) board of directors February 8, 2022
